FOLH1 and neoplasm: Moreover, intratumoral administration of A10-Plk1 AsiC in LNCaP-bearing athymic mice resulted in significant tumor regression when compared to the corresponding controls, such as PSMA-negative cells (PC-3) and A10mut-Plk1 [58].